Evidence map›Paper›PMID 25477506›Full record

ArticleThe Journal of biological chemistry2015

The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells.

Angela L Davis, Shuxi Qiao, Jessica L Lesson, Montserrat Rojo de la Vega, Sophia L Park, Carol M Seanez, Vijay Gokhale, Christopher M Cabello, Georg T Wondrak

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Deuterium Oxide (DCancers · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The BPhotochemistry and photobiology · 2017
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Angela L DavisFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724.
Shuxi QiaoFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724.
Jessica L LessonFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724.
Montserrat Rojo de la VegaFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724.
Sophia L ParkFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724.
Carol M SeanezFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724.
Vijay GokhaleFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724.
Christopher M CabelloFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724.
Georg T WondrakFrom the Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724 wondrak@pharmacy.arizona.edu.
University of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
Targeting Glycolytic Control of Melanoma Cell SurvivalR01CA122484 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T · 2007 to 2011
$1.3M
Targeting colorectal carcinogenesis using a cinnamon-derived food factorR21CA166926 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T, ZHANG, DONNA D · 2013 to 2014
$358k
Testing feasibility of artemisinin-based synthetic-lethal suppression of skin phoR03CA167580 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T · 2012 to 2013
$152k
NCI NIH HHS CA023074NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA122484NCI NIH HHS R01CA122484NCI NIH HHS R03 CA167580NCI NIH HHS R03CA167580NCI NIH HHS R21 CA166926NCI NIH HHS R21CA166926NIEHS NIH HHS ES006694NIEHS NIH HHS ES007091NIEHS NIH HHS P30 ES006694NIEHS NIH HHS T32 ES007091
6 · The paper itself

Abstract

Pharmacological induction of proteotoxic stress is rapidly emerging as a promising strategy for cancer cell-directed chemotherapeutic intervention. Here, we describe the identification of a novel drug-like heat shock response inducer for the therapeutic induction of proteotoxic stress targeting malignant human melanoma cells. Screening a focused library of compounds containing redox-directed electrophilic pharmacophores employing the Stress & Toxicity PathwayFinder(TM) PCR Array technology as a discovery tool, a drug-like triphenylmethane-derivative (aurin; 4-[bis(p-hydroxyphenyl)methylene]-2,5-cyclohexadien-1-one) was identified as an experimental cell stress modulator that causes (i) heat shock factor transcriptional activation, (ii) up-regulation of heat shock response gene expression (HSPA6, HSPA1A, DNAJB4, HMOX1), (iii) early unfolded protein response signaling (phospho-PERK, phospho-eIF2α, CHOP (CCAAT/enhancer-binding protein homologous protein)), (iv) proteasome impairment with increased protein-ubiquitination, and (v) oxidative stress with glutathione depletion. Fluorescence polarization-based experiments revealed that aurin displays activity as a geldanamycin-competitive Hsp90α-antagonist, a finding further substantiated by molecular docking and ATPase inhibition analysis. Aurin exposure caused caspase-dependent cell death in a panel of human malignant melanoma cells (A375, G361, LOX-IMVI) but not in non-malignant human skin cells (Hs27 fibroblasts, HaCaT keratinocytes, primary melanocytes) undergoing the aurin-induced heat shock response without impairment of viability. Aurin-induced melanoma cell apoptosis depends on Noxa up-regulation as confirmed by siRNA rescue experiments demonstrating that siPMAIP1-based target down-regulation suppresses aurin-induced cell death. Taken together, our data suggest feasibility of apoptotic elimination of malignant melanoma cells using the quinone methide-derived heat shock response inducer aurin.

Indexed as

ApoptosisAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAurintricarboxylic AcidCell Line, TumorCell SurvivalDrug Screening Assays, AntitumorFlow CytometryGlutathioneHeat-Shock ProteinsHeat-Shock ResponseHumansIndolequinonesInhibitory Concentration 50KeratinocytesMelanocytesAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportaurinAurintricarboxylic AcidGlutathioneHeat-Shock ProteinsIndolequinonesNOXA1 protein, humanquinone methideRNA, Small InterferingApoptosisAurinDrug DiscoveryHeat Shock Protein 90 (Hsp90)Heat Shock ResponseMelanomaNoxaOxidative StressProteotoxic Stress

Identifiers

PMID25477506
PMCPMC4340407
OpenAlexW2038607608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.